A Study Investigating the Bioavailability of CBD and THC in an Emulsion Product in a Healthy Population
Status:
Completed
Trial end date:
2020-11-30
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the bioavailability of Cannabidiol (CBD) and
Tetrahydrocannabinol (THC) in an emulsion product against a comparator product. Thirty-two
participants will be randomized into a single-center, double-blind, parallel trial.
Participants will be dosed in clinic and blood and urine samples will be taken over a 12-hour
period. Blood and urine samples will also be collected for 48 hours post-dose at check-in
visits. Questionnaires regarding drug effects and cognitive function will also be completed
following each blood sampling. Participants who consumed the comparator product will be asked
to return to the clinic following a wash-out period of at least 45 days to consume the
emulsion product in-clinic and complete questionnaires at the same specified time points over
a 12-hour period.